InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib

You must log in or register to reply here.

Similar threads

A
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib
Replies
0
Views
3
Adorable Antelope
A
A
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
Replies
0
Views
2
Adorable Antelope
A
A
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting
Replies
0
Views
3
Adorable Antelope
A
A
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 D
Replies
0
Views
3
Adorable Antelope
A
M
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154
Replies
0
Views
2
Money - r/Investing
M

Members Online

No members online now.
Total: 340 (members: 0, guests: 340)

Trending Content

Latest Media

LASTHJ8.mp4
Battlefield 4 2021.01.07 - 12.00.46.03.DVR-1.mp4
PERKY.png
Image1.png
Image1.jpg
holy-necrobump-batman.jpg

Featured Content

Latest Forum Posts

Forum Statistics

Threads
180,501
Messages
181,582
Members
80
Latest member
Roger Ebert
Top